scispace - formally typeset
K

Kollengode Ramanathan

Researcher at National University of Singapore

Publications -  102
Citations -  1840

Kollengode Ramanathan is an academic researcher from National University of Singapore. The author has contributed to research in topics: Medicine & Extracorporeal membrane oxygenation. The author has an hindex of 11, co-authored 61 publications receiving 757 citations. Previous affiliations of Kollengode Ramanathan include National University of Health Sciences & Bond University.

Papers
More filters
Journal ArticleDOI

Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases.

TL;DR: ECMO preparedness for the COVID-19 pandemic is important in view of the high transmission rate of the virus and respiratory-related mortality and ensuring that systems enable safe and coordinated movement of critically ill patients, staff, and equipment is important to improve ECMO access.
Journal ArticleDOI

Extracorporeal membrane oxygenation for COVID-19: a systematic review and meta-analysis.

TL;DR: Venovenous ECMO appears to be an effective intervention in selected patients with COVID-19-related ARDS, and survival outcomes were presented as pooled proportions while continuous outcomes were present as pooled means, both with corresponding 95% confidence intervals [CIs].
Journal ArticleDOI

Myopericarditis following COVID-19 vaccination and non-COVID-19 vaccination: a systematic review and meta-analysis

TL;DR: In this paper , the authors conducted a systematic review and meta-analysis, searching four international databases from Jan 1, 1947, to Dec 31, 2021, for studies in English reporting on the incidence of myopericarditis following vaccination (the primary outcome).
Journal ArticleDOI

Myopericarditis following COVID-19 vaccination and non-COVID-19 vaccination: a systematic review and meta-analysis

TL;DR: The overall risk of myopericarditis after receiving a COVID-19 vaccine is low, however, younger males have an increased incidence of myOperaarditis, particularly after receiving mRNA vaccines.